Skip to content
ProcedureFinder
Find a Provider
Home / Glossary / 503A compounding
Glossary term

503A compounding

A pharmacy designation for compounded medications prepared for individual patients. BPC-157 was removed from 503A eligibility in 2023.

Related Procedures

503A compounding appears in the following procedure guides on ProcedureFinder:

Peptides
BPC-157 Peptide Therapy
A 15-amino-acid pentadecapeptide derived from a gastric protein, marketed for tendon, ligament, and gut healing. Currently restricted by FDA from 503A compounding.

← Browse the full glossary